These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16932586)

  • 21. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 22. DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina.
    Cardiovasc J Afr; 2008; 19(3):174. PubMed ID: 18568187
    [No Abstract]   [Full Text] [Related]  

  • 23. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trials.
    Marler J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():42. PubMed ID: 15512869
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Short-term double-blind vs placebo trial of L-threonine in amyotrophic lateral sclerosis].
    Blin O; Serratrice G; Pouget J; Aubrespy G; Guelton C; Crevat A
    Presse Med; 1989 Sep; 18(30):1469-70. PubMed ID: 2534171
    [No Abstract]   [Full Text] [Related]  

  • 27. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS.
    MacGowan DJ; Scelsa SN; Imperato TE; Liu KN; Baron P; Polsky B
    Neurology; 2007 May; 68(22):1944-6. PubMed ID: 17536052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentoxifylline for intermittent claudication.
    Med Lett Drugs Ther; 1984 Nov; 26(675):103-4. PubMed ID: 6390108
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of lithium in ALS remains unknown.
    Saute JA; Valler L; Schestatsky P
    Amyotroph Lateral Scler; 2010 Dec; 11(6):574. PubMed ID: 20735282
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mobitz type II atrioventricular block as a side effect of pentoxifylline].
    Kalinina NN; Belaĭ IM; Grusha VN
    Klin Med (Mosk); 1996; 74(3):59. PubMed ID: 8926709
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
    Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
    Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in external respiration due to vasoactive therapy in patients with heart failure].
    Koshlia VI; Maliukova NG
    Klin Med (Mosk); 1995; 73(2):63. PubMed ID: 7609430
    [No Abstract]   [Full Text] [Related]  

  • 33. How beneficial is noninvasive ventilation in patients with amyotrophic lateral sclerosis?
    Lechtzin N
    Nat Clin Pract Neurol; 2006 Jul; 2(7):356-7. PubMed ID: 16932582
    [No Abstract]   [Full Text] [Related]  

  • 34. Urticaria due to pentoxyfylline.
    Gonzalez-Mahave I; Del Pozo MD; Blasco A; Lobera T; Venturini M
    Allergy; 2005 May; 60(5):705. PubMed ID: 15813823
    [No Abstract]   [Full Text] [Related]  

  • 35. [Supplementary enzyme treatment of urinary tract infections].
    Naber K
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 9():S327-30. PubMed ID: 19085664
    [No Abstract]   [Full Text] [Related]  

  • 36. [Attempts at treatment of amyotrophic lateral sclerosis].
    Domzal T; Ilnicki S
    Wiad Lek; 1974 Jun; 27(11):955-7. PubMed ID: 4839886
    [No Abstract]   [Full Text] [Related]  

  • 37. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
    Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM
    Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A preliminary report of treatment of transient cerebral ischemic attacks with BL 191 (author's transl)].
    Chen HB
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Feb; 13(2):97-9. PubMed ID: 7428559
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II/III randomized trial of TCH346 in patients with ALS.
    Miller R; Bradley W; Cudkowicz M; Hubble J; Meininger V; Mitsumoto H; Moore D; Pohlmann H; Sauer D; Silani V; Strong M; Swash M; Vernotica E;
    Neurology; 2007 Aug; 69(8):776-84. PubMed ID: 17709710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
    Rabkin JG; Gordon PH; McElhiney M; Rabkin R; Chew S; Mitsumoto H
    Muscle Nerve; 2009 Mar; 39(3):297-303. PubMed ID: 19208404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.